Loading...
Loading...
Contributors:
Dataset URI:
8822fe7a-882a-412e-9731-dbbd24c8ab37The study is intended to test efficacy, safety and tolerability of two doses of Mirabegron against placebo and compare the efficacy and safety with active comparator in patients with symptoms of overactive bladder.
Keyword(s):
Mirabegron; Overactive Bladder Syndrome; Placebo to Mirabegron; Placebo to Tolterodine; Tolterodine.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)